medical guideline

首页 肿瘤学指南 卵巢肿瘤 详情

SEOM Clinical Guideline in Ovarian Cancer (2020)

原文:2021年 发布于 Clinical and Translational Oncology 23卷 第5期 961-968 浏览量:376 原文链接

作者: Spanish Society of Medical Oncology

归属分类: 所属人体系统: 生殖 | 分类: 卵巢肿瘤

关键词: Diagnosis Guideline Ovarian Cancer Treatment


Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer remains the leading cause of death from gynecologic cancer. In the last decade, there have been important advances both in systemic and surgical treatment. However, there is no doubt that the incorporation of PARP inhibitors as maintenance after the response to platinum-based chemotherapy, first in recurrent disease and recently also in first line, will change the natural history of the disease.The objective of this guide is to summarize the current evidence for the diagnosis, treatment, and follow-up of ovarian cancer, and to provide evidence-based recommendations for clinical practice.